自定义搜索

Best of Show Awards Winners Named at Bio-IT World Conference & Expo
Products from Aspera, CLC Bio, Maxis IT and Rescentris recognized for their innovation across the life sciences research, discovery, and clinical trials process.

Cancer Researcher Dan Von Hoff, M.D. Advocates for "Context of Vulnerability," A Powerful New Paradigm for Targeted Drug Development
Renowned cancer researcher Dr. Daniel Von Hoff and his team at TGen are fervent believers in a new approach to developing novel therapies for patients with pancreatic cancer. They are guided by a rationale dubbed the "context of vulnerability." Dr. Von Hoff provides case studies and explains how this powerful paradigm has already led to promising discoveries and is changing the future of oncology drug development. The complete interview is available for download from Medelis, an oncology contract research organization providing worldwide oncology clinical trial design, management and execution.

OnCore® System Supporting Research Informatics Needs of the University of Wisconsin's Institute for Clinical and Translational Research
A proven and widely adopted research informatics platform, OnCore®, achieved another milestone this fall with the implementation at a world-class multidisciplinary research organization. At the end of September, the University of Wisconsin Institute for Clinical and Translational Research (UWICTR) began using OnCore to handle their clinical research data collection and administration needs. OnCore is the flagship product of PercipEnz Technologies, Inc., a software development company specializing in clinical and translational research informatics for midsized to large organizations.

MDS Pharma Services Completes 100th Phase I Study With Strategic Partner Daiichi Sankyo
U.S. Contract Research Organization and leading Japanese pharmaceutical company extend long-term alliance to 2011.